Skip to main content
Top
Published in: Archives of Virology 3/2019

01-03-2019 | Retrovirus | Original Article

Molecular dynamics of koala retrovirus infection in captive koalas in Japan

Authors: Mohammad Enamul Hoque Kayesh, Osamu Yamato, Mohammad Mahbubur Rahman, Md Abul Hashem, Fumie Maetani, Taiki Eiei, Kyoya Mochizuki, Hiroko Sakurai, Kyoko Tsukiyama-Kohara

Published in: Archives of Virology | Issue 3/2019

Login to get access

Abstract

Koala retrovirus (KoRV) is a gammaretrovirus that is becoming endogenous in koalas. Here, we explored the dynamics of KoRV infection in captive koalas in Japan. We isolated peripheral blood mononuclear cells (PBMCs) from 11 koalas, from which we extracted the KoRV genome. We found the prevalence of KoRV provirus in the koalas to be 100%, and the copy number of KoRV proviral DNA in genomic DNA isolated from PBMCs was variable. The KoRV envelope genes from 11 koalas were sequenced and all were found to be KoRV type A. Nucleotide substitution analysis revealed differences in the KoRV env gene sequences of parents and their offspring. Although no viral KoRV RNA was detected in plasma of healthy koalas, a high copy number was found in plasma of a diseased koala (#6). Hematological analysis showed a high white blood cell (WBC) count in the blood of koala #6. Notably, when retested ~ 5 months later, koala #6 was found to be negative for KoRV in plasma, and the WBC count was within the normal range. Therefore, KoRV in the plasma could be a possible indicator of koala health. We also investigated KoRV growth in concanavalin-A-stimulated koala PBMCs by measuring the KoRV provirus copy number in gDNA and the KoRV RNA copy number in cells and culture supernatants by real-time PCR at days 4, 7, and 14 post-culture. We also observed that KoRV isolates were able to infect HEK293T cells. These findings could enhance our understanding of the dynamics of KoRV and its pathogenesis in koalas.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rasmussen HB (1997) Interactions between exogenous and endogenous retroviruses. J Biomed Sci 4:1–8PubMed Rasmussen HB (1997) Interactions between exogenous and endogenous retroviruses. J Biomed Sci 4:1–8PubMed
2.
go back to reference Gifford R, Tristem M (2003) The evolution, distribution and diversity of endogenous retroviruses. Virus Genes 26:291–315CrossRefPubMed Gifford R, Tristem M (2003) The evolution, distribution and diversity of endogenous retroviruses. Virus Genes 26:291–315CrossRefPubMed
3.
go back to reference Bock M, Stoye JP (2000) Endogenous retroviruses and the human germline. Curr Opin Genet Dev 10:651–655CrossRefPubMed Bock M, Stoye JP (2000) Endogenous retroviruses and the human germline. Curr Opin Genet Dev 10:651–655CrossRefPubMed
4.
go back to reference Boeke JD, Stoye JP (1997) Retrotransposons, endogenous retroviruses, and the evolution of retroelements. In: Coffin JM, Hughes SH, Varmus HE (eds) Retroviruses. Cold Spring Harbor, Cold Spring Harbor Laboratory, New York, pp 343–346 Boeke JD, Stoye JP (1997) Retrotransposons, endogenous retroviruses, and the evolution of retroelements. In: Coffin JM, Hughes SH, Varmus HE (eds) Retroviruses. Cold Spring Harbor, Cold Spring Harbor Laboratory, New York, pp 343–346
5.
go back to reference Hanger JJ, Bromham LD, McKee JJ, O’Brien TM, Robinson WF (2000) The nucleotide sequence of Koala (Phascolactos cinereus) retrovirus: a novel type C endogenous virus related to Gibbon ape leukemia virus. J Virol 74:4264–4272CrossRefPubMedPubMedCentral Hanger JJ, Bromham LD, McKee JJ, O’Brien TM, Robinson WF (2000) The nucleotide sequence of Koala (Phascolactos cinereus) retrovirus: a novel type C endogenous virus related to Gibbon ape leukemia virus. J Virol 74:4264–4272CrossRefPubMedPubMedCentral
6.
go back to reference Tarlinton R, Meers J, Hanger J, Young P (2005) Real-time reverse transcriptase PCR for the endogenous koala retrovirus reveals an association between plasma viral load and neoplastic disease in koalas. J Gen Virol 86:783–787CrossRefPubMed Tarlinton R, Meers J, Hanger J, Young P (2005) Real-time reverse transcriptase PCR for the endogenous koala retrovirus reveals an association between plasma viral load and neoplastic disease in koalas. J Gen Virol 86:783–787CrossRefPubMed
9.
go back to reference Simmons GS, Young PR, Hanger JJ, Jones K, Clarke D, McKee JJ, Meers J (2012) Prevalence of koala retrovirus in geographically diverse populations in Australia. Aust Vet J 90:404–409CrossRefPubMed Simmons GS, Young PR, Hanger JJ, Jones K, Clarke D, McKee JJ, Meers J (2012) Prevalence of koala retrovirus in geographically diverse populations in Australia. Aust Vet J 90:404–409CrossRefPubMed
11.
go back to reference Shaw G, Morse S, Ararat M, Graham FL (2002) Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J 16:869–871CrossRefPubMed Shaw G, Morse S, Ararat M, Graham FL (2002) Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J 16:869–871CrossRefPubMed
12.
go back to reference Miyazawa T, Shojima T, Yoshikawa R, Ohata T (2011) Isolation of koala retroviruses from koalas in Japan. J Vet Med Sci 73:65–70CrossRefPubMed Miyazawa T, Shojima T, Yoshikawa R, Ohata T (2011) Isolation of koala retroviruses from koalas in Japan. J Vet Med Sci 73:65–70CrossRefPubMed
13.
go back to reference Tarlinton R, Meers J, Young P (2006) Retroviral invasion of the koala genome. Nature 422:79–81CrossRef Tarlinton R, Meers J, Young P (2006) Retroviral invasion of the koala genome. Nature 422:79–81CrossRef
14.
go back to reference Kumar S, Stecher G, Tamura K (2016) MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol 33:1870–1874CrossRef Kumar S, Stecher G, Tamura K (2016) MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol 33:1870–1874CrossRef
16.
go back to reference Shojima T, Hoshino S, Abe M, Yasuda J, Shogen H, Kobayashi T, Miyazawa T (2013) Construction and characterization of an infectious molecular clone of koala retrovirus. J Virol 87:5081–5088CrossRefPubMedPubMedCentral Shojima T, Hoshino S, Abe M, Yasuda J, Shogen H, Kobayashi T, Miyazawa T (2013) Construction and characterization of an infectious molecular clone of koala retrovirus. J Virol 87:5081–5088CrossRefPubMedPubMedCentral
17.
go back to reference Nitta T, Ha D, Galvez F, Miyazawa T, Fan H (2015) Human and murine APOBEC3s restrict replication of koala retrovirus by different mechanisms. Retrovirology 12:68CrossRefPubMedPubMedCentral Nitta T, Ha D, Galvez F, Miyazawa T, Fan H (2015) Human and murine APOBEC3s restrict replication of koala retrovirus by different mechanisms. Retrovirology 12:68CrossRefPubMedPubMedCentral
Metadata
Title
Molecular dynamics of koala retrovirus infection in captive koalas in Japan
Authors
Mohammad Enamul Hoque Kayesh
Osamu Yamato
Mohammad Mahbubur Rahman
Md Abul Hashem
Fumie Maetani
Taiki Eiei
Kyoya Mochizuki
Hiroko Sakurai
Kyoko Tsukiyama-Kohara
Publication date
01-03-2019
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 3/2019
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-019-04149-5

Other articles of this Issue 3/2019

Archives of Virology 3/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine